Correlation Between Chicago Atlantic and Bristol Myers

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Chicago Atlantic and Bristol Myers at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chicago Atlantic and Bristol Myers into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chicago Atlantic BDC, and Bristol Myers Squibb, you can compare the effects of market volatilities on Chicago Atlantic and Bristol Myers and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chicago Atlantic with a short position of Bristol Myers. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chicago Atlantic and Bristol Myers.

Diversification Opportunities for Chicago Atlantic and Bristol Myers

0.42
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Chicago and Bristol is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Chicago Atlantic BDC, and Bristol Myers Squibb in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bristol Myers Squibb and Chicago Atlantic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chicago Atlantic BDC, are associated (or correlated) with Bristol Myers. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bristol Myers Squibb has no effect on the direction of Chicago Atlantic i.e., Chicago Atlantic and Bristol Myers go up and down completely randomly.

Pair Corralation between Chicago Atlantic and Bristol Myers

Given the investment horizon of 90 days Chicago Atlantic BDC, is expected to generate 0.73 times more return on investment than Bristol Myers. However, Chicago Atlantic BDC, is 1.36 times less risky than Bristol Myers. It trades about 0.16 of its potential returns per unit of risk. Bristol Myers Squibb is currently generating about 0.09 per unit of risk. If you would invest  1,045  in Chicago Atlantic BDC, on October 1, 2024 and sell it today you would earn a total of  162.00  from holding Chicago Atlantic BDC, or generate 15.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Chicago Atlantic BDC,  vs.  Bristol Myers Squibb

 Performance 
       Timeline  
Chicago Atlantic BDC, 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Chicago Atlantic BDC, are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain technical and fundamental indicators, Chicago Atlantic displayed solid returns over the last few months and may actually be approaching a breakup point.
Bristol Myers Squibb 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady primary indicators, Bristol Myers may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Chicago Atlantic and Bristol Myers Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Chicago Atlantic and Bristol Myers

The main advantage of trading using opposite Chicago Atlantic and Bristol Myers positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chicago Atlantic position performs unexpectedly, Bristol Myers can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol Myers will offset losses from the drop in Bristol Myers' long position.
The idea behind Chicago Atlantic BDC, and Bristol Myers Squibb pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities